Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission

Background/Aims Serum leucine-rich alpha-2 glycoprotein (LRG) is a potential biomarker of Crohn’s disease (CD). This study aimed to evaluate the usefulness of LRG in predicting clinical relapse in patients in remission with CD. Methods This retrospective observational study assessed the relationship...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Naohiro Nakamura, Yusuke Honzawa, Yuka Ito, Yasuki Sano, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Takashi Tomiyama, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui, Makoto Naganuma
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Korean Association for the Study of Intestinal Diseases 2025-04-01
Schriftenreihe:	Intestinal Research
Schlagworte:	crohn disease leucine-rich alpha-2 glycoprotein biomarkers
Online-Zugang:	http://irjournal.org/upload/pdf/ir-2024-00042.pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!